Citation link: http://dx.doi.org/10.25819/ubsi/10247
DC FieldValueLanguage
crisitem.author.orcid0000-0002-8088-2511-
crisitem.author.orcid0000-0001-5968-429X-
crisitem.author.orcid0000-0001-6940-3551-
crisitem.author.orcid0000-0003-2433-6652-
dc.contributor.authorPlanert, Jari-
dc.contributor.authorMachulska, Alla-
dc.contributor.authorHildebrand, Anne‑Sophie-
dc.contributor.authorRoesmann (Keuper), Kati-
dc.contributor.authorOtto, Esra-
dc.contributor.authorKlucken, Tim-
dc.date.accessioned2023-01-16T14:53:53Z-
dc.date.available2023-01-16T14:53:53Z-
dc.date.issued2022de
dc.descriptionFinanziert im Rahmen der DEAL-Verträge durch die Universitätsbibliothek Siegende
dc.description.abstractBackground Cognitive behavioral therapy is the first-line treatment for patients with panic disorder (PD) and agoraphobia (AG). Yet, many patients remain untreated due to limited treatment resources. Digital self-guided short-term treatment applications may help to overcome this issue. While some therapeutic applications are already supported by health insurance companies, data on their efficacy is limited. The current study investigates the effect of self-guided digital treatment comprising psychoeducation and virtual reality exposure therapy (VRET). Methods Thirty patients diagnosed with PD, AG, or panic disorder with agoraphobia (PDA) will be randomly assigned to either the experimental group (EG) or the control group (CG). Participants of both groups will undergo baseline diagnostics in the first two sessions. The subsequent treatment for the EG consists of a self-guided 6-week phase of application-based psychoeducation, one therapy session preparing for the VRET, and 4 weeks of application-based self-guided VRET. To control for the potential effects of the therapy session with the therapist, the CG will receive relaxation and stress-reduction training instead. All patients will then undergo a closing session which terminates with the post-assessment (~ 10 weeks after baseline assessment) and a follow-up assessment 6 weeks following the closing session. Symptom severity (primary outcome) will be assessed at baseline, interim, post-treatment, and follow-up. Additionally, remission status (secondary outcome) will be obtained at follow-up. Both measures will be compared between the groups. Discussion The current study aims at providing insights into the efficacy of short-term treatment applications including psychoeducation and self-guided VRET. If successful, this approach might be a feasible and promising way to ease the burden of PD, AG, and PDA on the public health system and contribute to a faster access to treatment.en
dc.identifier.doihttp://dx.doi.org/10.25819/ubsi/10247-
dc.identifier.urihttps://dspace.ub.uni-siegen.de/handle/ubsi/2441-
dc.identifier.urnurn:nbn:de:hbz:467-24416-
dc.language.isoende
dc.rightsNamensnennung 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.sourceTrials ; 23, article number 426. - https://doi.org/10.1186/s13063-022-06366-xde
dc.subject.ddc150 Psychologiede
dc.subject.otherVirtual realityen
dc.subject.otherCognitive behavioral therapyen
dc.subject.otherAgoraphobiaen
dc.subject.otherPanic disorderen
dc.subject.otherSelf-guided helpen
dc.subject.otherShort-term treatmenten
dc.subject.otherE-healthen
dc.subject.swbVirtuelle Realitätde
dc.subject.swbKognitive Verhaltenstherapiede
dc.subject.swbE-Healthde
dc.subject.swbPaniksyndromde
dc.subject.swbAgoraphobiede
dc.subject.swbSelbsthilfede
dc.titleSelf-guided digital treatment with virtual reality for panic disorder and agoraphobiaen
dc.typeArticlede
item.fulltextWith Fulltext-
ubsi.origin.dspace51-
ubsi.publication.affiliationFakultät V - Lebenswissenschaftliche Fakultätde
ubsi.source.doi10.1186/s13063-022-06366-x-
ubsi.source.issn1745-6215-
ubsi.source.issued2022de
ubsi.source.pages9de
ubsi.source.placeLondonde
ubsi.source.publisherBioMed Centralde
ubsi.source.titleTrialsde
ubsi.source.volume23de
ubsi.subject.ghbsHQNde
ubsi.subject.ghbsHSGde
ubsi.subject.ghbsHVQHde
ubsi.subject.ghbsHVRGde
ubsi.title.alternativea study protocol for a randomized controlled trialen
Appears in Collections:Geförderte Open-Access-Publikationen
Files in This Item:

This item is protected by original copyright

Show simple item record

Page view(s)

265
checked on Apr 26, 2024

Download(s)

148
checked on Apr 26, 2024

Google ScholarTM

Check

Altmetric


This item is licensed under a Creative Commons License Creative Commons